Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Newer anticonvulsant drugs: role of pharmacology, drug interactions and adverse reactions in drug choice.

Natsch S, Hekster YA, Keyser A, Deckers CL, Meinardi H, Renier WO.

Drug Saf. 1997 Oct;17(4):228-40. Review.

PMID:
9352959
2.

The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine.

Perucca E, Bialer M.

Clin Pharmacokinet. 1996 Jul;31(1):29-46. Review.

PMID:
8827398
3.

Choice and use of newer anticonvulsant drugs in older patients.

Willmore LJ.

Drugs Aging. 2000 Dec;17(6):441-52. Review.

PMID:
11200305
4.

[Antiepileptic drugs in North America].

Akiyama T, Otsubo H.

Brain Nerve. 2010 May;62(5):519-26. Review. Japanese.

PMID:
20450099
5.

Newer anticonvulsants: comparative review of drug interactions and adverse effects.

Sabers A, Gram L.

Drugs. 2000 Jul;60(1):23-33. Review.

PMID:
10929928
6.

Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?

Johannessen SI, Tomson T.

Clin Pharmacokinet. 2006;45(11):1061-75. Review.

PMID:
17048972
7.

New antiepileptic drugs: review on drug interactions.

Hachad H, Ragueneau-Majlessi I, Levy RH.

Ther Drug Monit. 2002 Feb;24(1):91-103. Review.

PMID:
11805729
8.

Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine.

Elwes RD, Binnie CD.

Clin Pharmacokinet. 1996 Jun;30(6):403-15. Review.

PMID:
8792055
9.

Adverse reactions to new anticonvulsant drugs.

Wong IC, Lhatoo SD.

Drug Saf. 2000 Jul;23(1):35-56. Review.

PMID:
10915031
10.

[Newer antiepileptic drugs].

Matsuura M.

No To Shinkei. 2007 Feb;59(2):147-56. Review. Japanese.

PMID:
17315756
11.

Drug interactions involving the new second- and third-generation antiepileptic drugs.

Johannessen Landmark C, Patsalos PN.

Expert Rev Neurother. 2010 Jan;10(1):119-40. doi: 10.1586/ern.09.136. Review.

PMID:
20021326
12.

The new generation of antiepileptic drugs: advantages and disadvantages.

Perucca E.

Br J Clin Pharmacol. 1996 Nov;42(5):531-43. Review.

13.

[Newer antiepileptic drugs].

Matsuura M.

Brain Nerve. 2007 Feb;59(2):147-56. Review. Japanese.

PMID:
17380779
14.
15.

Clinical pharmacology and therapeutic use of the new antiepileptic drugs.

Perucca E.

Fundam Clin Pharmacol. 2001 Dec;15(6):405-17. Review. Erratum in: Fundam Clin Pharmacol. 2002 Jun;16(3):249..

PMID:
11860529
16.
17.

Some common issues in the use of antiepileptic drugs.

Asconapé JJ.

Semin Neurol. 2002 Mar;22(1):27-39. Review.

PMID:
12170391
18.

Selection criteria for the clinical use of the newer antiepileptic drugs.

Deckers CL, Knoester PD, de Haan GJ, Keyser A, Renier WO, Hekster YA.

CNS Drugs. 2003;17(6):405-21. Review.

PMID:
12697000
19.

Place of newer antiepileptic drugs in the treatment of epilepsy.

Kälviäinen R, Keränen T, Riekkinen PJ Sr.

Drugs. 1993 Dec;46(6):1009-24. Review.

PMID:
7510609
20.

The new antiepileptic drugs: pharmacological and clinical aspects.

Gatti G, Bonomi I, Jannuzzi G, Perucca E.

Curr Pharm Des. 2000 May;6(8):839-60. Review.

PMID:
10828310

Supplemental Content

Support Center